Hepatitis B control by 2012 in the WHO Western Pacific Region: Rationale and implications

Bulletin of the World Health Organization

Volumn 87, Issue 9, 2009, Pages 707-713

  Rani, Manju ^a   Yang, Baoping ^a   Nesbit, Richard ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANTIGEN; CERTIFICATION; CORRELATION; DISEASE CONTROL; DISEASE PREVALENCE; DOSE-RESPONSE RELATIONSHIP; FUTURE PROSPECT; HEALTH MONITORING; HEALTH POLICY; HEALTH RISK; HEPATITIS; IMMUNIZATION; INFANT FEEDING; INFECTIOUS DISEASE; POLITICAL PARTICIPATION; STRATEGIC APPROACH; VACCINATION; WORLD HEALTH ORGANIZATION;

HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION CONTROL; PREVENTIVE MEDICINE; REVIEW; SEROPREVALENCE; WORLD HEALTH ORGANIZATION;

ASIA; AUSTRALASIA; HEALTHY PEOPLE PROGRAMS; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; IMMUNIZATION PROGRAMS; WORLD HEALTH ORGANIZATION;

AFRICA; ASIA; EURASIA;

EID: 70249144017     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.08.059220     Document Type: Review

References (23)

1. Miller M, Barrett S, Henderson DA. Control and eradication. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, eds. Disease control priorities in developing countries, 2nd ed. New York, NY, & Washington, DC: Oxford University Press and The World Bank; 2006.
2. Bhattacharya S. The local bases of global public health: complexities and opportunities. Bull World Health Organ 2008;86:163. PMID:18368197
3. Molyneux DH, Hopkins DR, Zagaria N. Disease eradication, elimination and control: the need for accurate and consistent usage. Trends Parasitol 2004;20:347-351 PMID:15246314 doi:10.1016/j.pt.2004.06.004 (Pubitemid 38916521)
4. Measles elimination, hepatitis B control and poliomyelitis eradication. [Regional committee meeting resolution WPR/RC56.R8]. Manila: World Health Organization Regional Office for the Western Pacific; 2005. Available from: http://www.wpro.who.int/rcm/en/archives/rc56/rc-resolutions/wpr-rc56-r08.htm [accessed on 2 June 2009].
5. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis H. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005;34:1329-1339 PMID:16249217 doi:10.1093/ije/dyi206 (Pubitemid 41819540)
6. Hall AJ, Wild CP. Liver cancer in low and middle income countries. BMJ 2003;326:994-995 PMID:12742895 doi:10.1136/bmj.326.7397.994
7. Teo EK, Fock KM. Hepatocellular carcinoma: an Asian perspective. Dig Dis 2001;19:263-268 PMID:11935085 doi:10.1159/000050692
8. Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut 1996;38 suppl 2;S39-42. PMID:8786052 doi:10.1136/gut.38.Suppl-2.S39
9. Liang XF, Chen YS, Wang XJ, He X, Chen LJ, Wang J, et al. A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old. Zhonghua Liu Xing Bing Xue Za Zhi 2005;26:655-658
10. Hipgrave DB, Nguyen TV, Vu MH, Hoang TL, Do TD, Tran NT, et al. Hepatitis B infection in rural Viet Nam and the implications for a national program of infant immunization. Am J Trop Med Hyg 2003;69:288-294 PMID:14628946
11. Clements CJ, Baoping Y, Crouch A, Hipgrave D, Mansoor O, Nelson CB, et al. Progress in the control of hepatitis B infection in the Western Pacific Region. Vaccine 2006;24:1975-1982 PMID:16361001 doi:10.1016/j.vaccine.2005.11. 035 (Pubitemid 43255137)
12. Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 1996;38 suppl 2;S18-23. PMID:8786047 doi:10.1136/gut.38. Suppl-2.S18
13. Nelson CB. Global and regional estimates of HBV-related disease burden. In: World Health Organization Regional Office for the Western Pacific's working group meeting on viral hepatitis B, Tokyo, Japan, 26-28 June 2002 (RS/2002/GE/05).
14. Global tuberculosis control: surveillance, planning, financing: WHO report. Geneva: World Health Organization; 2008.
15. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. PMID:15761078 doi:10.3322/canjclin.55.2.74
16. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-3044 PMID:16404738 doi:10.1002/ijc.21731
17. Death and DALY estimates by cause. Geneva: World Health Organization; 2004. Available from: http://www.who.int/entity/healthinfo/statistics/ bodgbddeathdalyestimates.xls [accessed on 2 June 2009].
18. World Health Organization. Expanded programme on immunization. Global advisory group - part I. Wkly Epidemiol Rec 1992;67:11-15 PMID:1736955
19. World Health Organization. Meeting of the Immunization Strategic Advisory Group of Experts, November 2007, conclusions and recommendations. Wkly Epidemiol Rec 2008;83:1-15. PMID:18175408
20. Wolfson LJ, Sterbel PM, Gacic-dobo M. Has the 2005 measles mortality reduction goal has been achieved? A natural history modelling study. Lancet 2007;369:191-200. PMID:17240285 doi:10.1016/S0140-6736(07)60107-X
21. Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Kimball AM. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med 2002;34:207-214 PMID:11817916 doi:10.1006/pmed.2001.0972 (Pubitemid 34971703)
22. Guidelines for certification of achievement of hepatitis B control goal in the Western Pacific Region. Manila: World Health Organization Regional Office for the Western Pacific; 2007. Available from: http://www.wpro. who.int/NR/rdonlyres/E0D43A33-1FC7-479D-B967-64D05E8E5291/0/ HepBControlCertifGuidelines.pdf [accessed on 2 June 2009].
23. Preventing mother-to-child transmission of hepatitis B: operational field guidelines for delivery of the birth dose of hepatitis B vaccine. Manila: World Health Organization Regional Office for the Western Pacific; 2006. Available from: http://www.wpro.who.int/NR/rdonlyres/B8D1C444-C7B9-43B2-95A2-16ED87C94B0B/ 0/HepBBirthDoseFieldGuidelines.pdf [accessed on 2 June 2009].